The recent air strike that resulted in the death of Izz al-Din al-Haddad adds to the tensions surrounding an already fragile ceasefire in the region.
Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
The pharmaceutical industry is witnessing various changes, including new hires and promotions. Ailux has appointed Maria Belvisi as its chief scientific officer.
This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.
The political landscape in the U.K. may influence drug pricing strategies, while the U.S. continues to press Germany for higher drug payments, amidst other health developments.
In the latest Pharmalittle update, the U.S. is applying pressure on Germany regarding drug pricing policies, alongside notable changes within the FDA and developments in biotech clinical trials.
In recent health news, the legality of mail-order abortion pills persists, while the Africa CDC has announced an Ebola outbreak in the DRC, among other updates.
Researchers from James Cook University reveal how a collaborative playlist helped cycling enthusiasts maintain social connections during pandemic lockdowns, offering insights into mental health support.
The DOJ has accused Yale and UCLA medical schools of potentially discriminatory admissions practices against white and Asian applicants, highlighting ongoing debates about equity in education.
The latest episode of 'The Readout LOUD' delves into significant health politics, highlighting Marty Makary's recent departure from the FDA and the implications for Senator Cassidy's position.
In a significant move towards reducing animal testing, the CDC plans to transfer more than 160 macaques to Born Free USA, a nonprofit sanctuary in Texas.
In a significant development, BeOne has received FDA approval for its lymphoma treatment. Meanwhile, Regenxbio is making strides in Duchenne gene therapy, among other biotech updates.
This edition of STAT Health Tech examines the reasons behind the absence of major digital health companies from Medicare's ACCESS pilot program, alongside other industry updates.
Biogen has shared mixed findings from a mid-stage trial for an Alzheimer’s treatment aimed at the tau protein, amidst other industry news.
A recent survey sheds light on the evolving partnerships between state Medicaid programs and public health agencies, revealing shared priorities and community health advancements.
A recent KFF Health Tracking Poll shows that many adults lack confidence in the independence of government health agencies responsible for food and drug safety, raising concerns about public health oversight.
The 1926 general strike in Britain faced mixed weather conditions, with a warm spell easing some challenges, while colder weather could have exacerbated the situation.
Two doctors from the CDC have addressed public fears regarding a hantavirus outbreak linked to a cruise ship, asserting that the overall risk to the public remains low.
Research highlights the importance of measuring PFAS levels in firefighter equipment, as wear and tear may affect the presence of these harmful 'forever chemicals'.
Vice President JD Vance has announced a deferral of $1.3 billion in Medicaid reimbursements to California, citing suspicions of fraud in federal health programs.